Enalapril Impurity 1 | CAS 105167-27-9 - Request Quote
Enalapril Impurity 1
| SZ CAT No: | SZ-E011019 |
| CAS No | 105167-27-9 |
| Mol.F. | C15H19NO5 |
| Mol.Wt. | 293.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Enalapril Impurity 1 is chemically ((S)-1-Ethoxy-1,4-dioxo-4-phenylbutan-2-yl)-D-alanine. Enalapril Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Enalapril Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Enalapril.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 105167-27-9
Purchase 105167-27-9
Order 105167-27-9
Enquire 105167-27-9
price of 105167-27-9
105167-27-9 Supplier
105167-27-9 Manufacturer
105167-27-9 Exporter
buy high quality Enalapril Impurity 1
Purchase Enalapril Impurity 1
Enalapril Impurity 1 suppliers
Enalapril Impurity 1 manufacturers
Enalapril Impurity 1 price
Order Enalapril Impurity 1
Enquire Enalapril Impurity 1
Enalapril Impurity 1 cost
Enalapril Impurity 1 Supplier
Enalapril Impurity 1 Distributor
Enalapril Impurity 1 for Method Validation
Enalapril Reference Standard
Enalapril Impurity 1 for ANDA Filing
Enalapril Impurity 1 for Forced Degradation Studies
Enalapril Impurity 1 Identification Standards
Enalapril Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.